Mediterranean Journal of Hematology and Infectious Diseases最新文献

筛选
英文 中文
Kikuchi-Fujimoto Disease and Hemophagocytic Lymphohistiocytosis: A Rare Combination of Two Rare Diseases. 菊池-藤本病和噬血细胞性淋巴组织细胞增多症:两种罕见疾病的罕见结合。
IF 1.5 4区 医学
Mediterranean Journal of Hematology and Infectious Diseases Pub Date : 2026-01-01 DOI: 10.4084/MJHID.2026.006
Mariam Markouli, Panagiotis Diamantopoulos, Asimina Chalioti, Stavroula Lontou, Marina Mantzourani
{"title":"Kikuchi-Fujimoto Disease and Hemophagocytic Lymphohistiocytosis: A Rare Combination of Two Rare Diseases.","authors":"Mariam Markouli, Panagiotis Diamantopoulos, Asimina Chalioti, Stavroula Lontou, Marina Mantzourani","doi":"10.4084/MJHID.2026.006","DOIUrl":"10.4084/MJHID.2026.006","url":null,"abstract":"","PeriodicalId":18498,"journal":{"name":"Mediterranean Journal of Hematology and Infectious Diseases","volume":"18 1","pages":"e2026006"},"PeriodicalIF":1.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12867015/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146119441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early Diagnosis of Gaucher Disease and ASMD in Sardinia: The "Ichnos" Project. 撒丁岛戈谢病和ASMD的早期诊断:“Ichnos”项目。
IF 1.5 4区 医学
Mediterranean Journal of Hematology and Infectious Diseases Pub Date : 2026-01-01 DOI: 10.4084/MJHID.2026.016
Alessandro Costa, Daniela Perra, Olga Mulas, Luigi Podda, Francesco Longu, Claudio Fozza, Angelo Palmas, Luigi Curreli, Maria Domenica Cappellini, Carmela Zizzo, Giovanni Caocci
{"title":"Early Diagnosis of Gaucher Disease and ASMD in Sardinia: The \"Ichnos\" Project.","authors":"Alessandro Costa, Daniela Perra, Olga Mulas, Luigi Podda, Francesco Longu, Claudio Fozza, Angelo Palmas, Luigi Curreli, Maria Domenica Cappellini, Carmela Zizzo, Giovanni Caocci","doi":"10.4084/MJHID.2026.016","DOIUrl":"10.4084/MJHID.2026.016","url":null,"abstract":"","PeriodicalId":18498,"journal":{"name":"Mediterranean Journal of Hematology and Infectious Diseases","volume":"18 1","pages":"e2026016"},"PeriodicalIF":1.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12867021/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146119387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pathogenetic Mechanism of Macular Edema During Treatment with Ibrutinib. 伊鲁替尼治疗期间黄斑水肿的发病机制。
IF 1.5 4区 医学
Mediterranean Journal of Hematology and Infectious Diseases Pub Date : 2026-01-01 DOI: 10.4084/MJHID.2026.009
Cristina Mauro, Livio Pupo, Lucia Cardillo, Fabiana Esposito, Elisa Buzzatti, Marco Lombardo, Massimo Cesareo, Adriano Venditti, Massimiliano Postorino, Maria Ilaria Del Principe
{"title":"Pathogenetic Mechanism of Macular Edema During Treatment with Ibrutinib.","authors":"Cristina Mauro, Livio Pupo, Lucia Cardillo, Fabiana Esposito, Elisa Buzzatti, Marco Lombardo, Massimo Cesareo, Adriano Venditti, Massimiliano Postorino, Maria Ilaria Del Principe","doi":"10.4084/MJHID.2026.009","DOIUrl":"10.4084/MJHID.2026.009","url":null,"abstract":"","PeriodicalId":18498,"journal":{"name":"Mediterranean Journal of Hematology and Infectious Diseases","volume":"18 1","pages":"e2026009"},"PeriodicalIF":1.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12867025/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146119373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of a New Scoring System for Treatment Failure in CML Patients on Tyrosine Kinase Inhibitors in a Real-World Setting. 在现实世界中验证一种新的酪氨酸激酶抑制剂治疗CML患者失败的评分系统。
IF 1.5 4区 医学
Mediterranean Journal of Hematology and Infectious Diseases Pub Date : 2026-01-01 DOI: 10.4084/MJHID.2026.013
Andrea Mattozzi, Eugenio Galli, Francesco Autore, Ilaria Pansini, Patrizia Chiusolo, Maria Colangelo, Simona Sica, Federica Sorà
{"title":"Validation of a New Scoring System for Treatment Failure in CML Patients on Tyrosine Kinase Inhibitors in a Real-World Setting.","authors":"Andrea Mattozzi, Eugenio Galli, Francesco Autore, Ilaria Pansini, Patrizia Chiusolo, Maria Colangelo, Simona Sica, Federica Sorà","doi":"10.4084/MJHID.2026.013","DOIUrl":"10.4084/MJHID.2026.013","url":null,"abstract":"","PeriodicalId":18498,"journal":{"name":"Mediterranean Journal of Hematology and Infectious Diseases","volume":"18 1","pages":"e2026013"},"PeriodicalIF":1.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12867017/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146119433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CD48 as a Novel Early Biomarker Complementing Procalcitonin and Lactate for Predicting Bacteremia in Pediatric Febrile Neutropenia: A Prospective Cohort Study. CD48作为一种补充降钙素原和乳酸盐的新型早期生物标志物,用于预测儿童发热性中性粒细胞减少症的菌血症:一项前瞻性队列研究
IF 1.5 4区 医学
Mediterranean Journal of Hematology and Infectious Diseases Pub Date : 2026-01-01 DOI: 10.4084/MJHID.2026.004
Neryal Tahta, Tuba Hilkay Karapınar, Sultan Okur Acar, Ayşe Erol, İlker Devrim, Yeşim Oymak, Salih Gözmen, Canan Raziye Vergin
{"title":"CD48 as a Novel Early Biomarker Complementing Procalcitonin and Lactate for Predicting Bacteremia in Pediatric Febrile Neutropenia: A Prospective Cohort Study.","authors":"Neryal Tahta, Tuba Hilkay Karapınar, Sultan Okur Acar, Ayşe Erol, İlker Devrim, Yeşim Oymak, Salih Gözmen, Canan Raziye Vergin","doi":"10.4084/MJHID.2026.004","DOIUrl":"10.4084/MJHID.2026.004","url":null,"abstract":"<p><strong>Background: </strong>Febrile neutropenia (FN) remains a frequent and potentially life-threatening complication in pediatric oncology, where prompt recognition of bacteremia is critical for risk-adapted therapy and antimicrobial stewardship. Traditional biomarkers such as C-reactive protein (CRP) and procalcitonin (PCT) are widely used, yet their early predictive value is inconsistent across studies. Cellular activation markers measured by flow cytometry, particularly CD48, have been scarcely investigated in this setting. This study aimed to evaluate conventional, metabolic, and immune biomarkers for predicting bacteremia in children with FN and to assess the incremental diagnostic value of CD48.</p><p><strong>Methods: </strong>This prospective single-center cohort enrolled 38 pediatric oncology patients presenting with 46 FN episodes over 9 months. Clinical data, blood cultures, and serial measurements of CRP, PCT, lactate, interleukin-6, interleukin-8, MCP-1, sTREM-1, CD48, and CD64 were obtained at 0, 24, 48, and 72 hours. Bacteremia was defined by positive culture for a recognized pathogen. Receiver operating characteristic (ROC) analyses were performed to determine the area under the curve (AUC), sensitivity, and specificity. A multivariable logistic regression model evaluated the combined performance of biomarkers.</p><p><strong>Results: </strong>Bacteremia occurred in 12 (26.1%) FN episodes. Sepsis, tachycardia, and elevated lactate were more common among bacteremic patients. CRP showed limited early discrimination (AUC 0.62 on day 2) but improved by day 4 (AUC 0.74). PCT was consistently higher in bacteremia (AUC 0.89 at day 4), and lactate demonstrated strong early predictive value (AUC 0.81). CD48 was significantly elevated from 0-24 h (AUC 0.78), outperforming CD64 (AUC 0.60) and preceding the rise in CRP. In combined modeling, PCT + CD48 + lactate achieved the highest discrimination (AUC 0.92; sensitivity 92%, specificity 85%). Post-hoc power analysis showed 82% power to detect AUC differences ≥0.15.</p><p><strong>Conclusion: </strong>Integration of CD4 with PCT and Lactate markedly improved diagnostic accuracy in this cohort; however, given the limited number of bacteremic episodes, these findings should be considered exploratory and require external validation in larger, multicenter studies before clinical implementation.</p>","PeriodicalId":18498,"journal":{"name":"Mediterranean Journal of Hematology and Infectious Diseases","volume":"18 1","pages":"e2026004"},"PeriodicalIF":1.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12867028/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146118937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subtype Distribution and Mutation Spectrum of Thalassemia in Children Under 10 Years in Northern Vietnam. 越南北部地区10岁以下儿童地中海贫血亚型分布及突变谱
IF 1.5 4区 医学
Mediterranean Journal of Hematology and Infectious Diseases Pub Date : 2026-01-01 DOI: 10.4084/MJHID.2026.002
Ha Thanh Nguyen, Thi Thu Ha Nguyen, Thi Chi Nguyen, Thi Nguyet Anh Phi, Thi Thu Huyen Le, Phuong Linh Hoang, Duc Binh Vu, Ngoc Dung Nguyen
{"title":"Subtype Distribution and Mutation Spectrum of Thalassemia in Children Under 10 Years in Northern Vietnam.","authors":"Ha Thanh Nguyen, Thi Thu Ha Nguyen, Thi Chi Nguyen, Thi Nguyet Anh Phi, Thi Thu Huyen Le, Phuong Linh Hoang, Duc Binh Vu, Ngoc Dung Nguyen","doi":"10.4084/MJHID.2026.002","DOIUrl":"10.4084/MJHID.2026.002","url":null,"abstract":"<p><strong>Background: </strong>Thalassemia is a common hereditary hemoglobin disorder in Vietnam. Elucidating the epidemiological and genetic patterns in children is essential for developing screening and prevention strategies.</p><p><strong>Methods: </strong>A retrospective analysis of 1,240 children under 10 years of age with Thalassemia treated at the National Institute of Hematology and Blood Transfusion in Vietnam, between 2014 and 2023.</p><p><strong>Results: </strong>The median age at treatment initiation was 1 year (range 0-9 years), with 94.5% of patients aged 0-5 years. Children born after 2020 were diagnosed and treated earlier than those born before 2020 (0 year (range 0-2 years) vs 1 year (range 0-9 years); p < 0.0001), concurrent with the implementation of the national prenatal screening program. β-thalassemia and β-thalassemia/HbE accounted for nearly 90% of cases, with subtype distribution varying by ethnicity and region. β-thalassemia/HbE predominated in the Northwest and North Central regions, particularly among the Thai and Muong populations. In contrast, β-thalassemia was more prevalent in the Northeast, notably among the Tay and Nung populations. Eight α-globin and thirteen β-globin mutated types were detected. The common β-globin variants (CD17, CD41/42, CD71/72, -28, and IVSI-1) and HbE (CD26) mirror patterns reported in neighboring Laos and Guangxi Province, China. For α-globin genotypes, --<sup>SEA</sup> (49.83%), Hb CS (31.53%), and -α<sup>3.7</sup> (8.47%) were most frequent.</p><p><strong>Conclusion: </strong>Geography, ethnicity, and genetic background strongly shape Thalassemia epidemiology in Northern Vietnam. Targeted genetic counseling, early carrier screening, and region-focused community programs are urgently needed to reduce disease burden in high-risk populations.</p>","PeriodicalId":18498,"journal":{"name":"Mediterranean Journal of Hematology and Infectious Diseases","volume":"18 1","pages":"e2026002"},"PeriodicalIF":1.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12867033/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146119353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Community-acquired Carbapenem-resistant Escherichia coli Bacteremia Associated with Transient Aplastic Crisis. 社区获得性碳青霉烯耐药大肠杆菌血症与短暂再生危机相关。
IF 1.5 4区 医学
Mediterranean Journal of Hematology and Infectious Diseases Pub Date : 2026-01-01 DOI: 10.4084/MJHID.2026.005
Yu Chen, Jin Zhang, Wenqiang Kong
{"title":"Community-acquired Carbapenem-resistant <i>Escherichia coli</i> Bacteremia Associated with Transient Aplastic Crisis.","authors":"Yu Chen, Jin Zhang, Wenqiang Kong","doi":"10.4084/MJHID.2026.005","DOIUrl":"10.4084/MJHID.2026.005","url":null,"abstract":"","PeriodicalId":18498,"journal":{"name":"Mediterranean Journal of Hematology and Infectious Diseases","volume":"18 1","pages":"e2026005"},"PeriodicalIF":1.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12867019/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146119205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Hemolytic Anemia Following Rasburicase in a Very Late Post-Transplant Relapse of Acute Myeloid Leukemia. 急性骨髓性白血病移植后极晚复发的Rasburicase引起的急性溶血性贫血。
IF 1.5 4区 医学
Mediterranean Journal of Hematology and Infectious Diseases Pub Date : 2026-01-01 DOI: 10.4084/MJHID.2026.003
Gianluca Cavallaro, Federico Lussana, Marco Frigeni, Maria Caterina Micò, Alessandra Algarotti, Anna Grassi, Orietta Spinelli, Chiara Pavoni, Alessandro Rambaldi
{"title":"Acute Hemolytic Anemia Following Rasburicase in a Very Late Post-Transplant Relapse of Acute Myeloid Leukemia.","authors":"Gianluca Cavallaro, Federico Lussana, Marco Frigeni, Maria Caterina Micò, Alessandra Algarotti, Anna Grassi, Orietta Spinelli, Chiara Pavoni, Alessandro Rambaldi","doi":"10.4084/MJHID.2026.003","DOIUrl":"10.4084/MJHID.2026.003","url":null,"abstract":"","PeriodicalId":18498,"journal":{"name":"Mediterranean Journal of Hematology and Infectious Diseases","volume":"18 1","pages":"e2026003"},"PeriodicalIF":1.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12880808/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146142730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
End-of-Life Care in Sickle Cell Disease and Transfusion-Dependent β-Thalassemia: Clinical, Psychosocial, and Ethical Considerations. 镰状细胞病和输血依赖性β-地中海贫血的临终关怀:临床、社会心理和伦理考虑。
IF 1.5 4区 医学
Mediterranean Journal of Hematology and Infectious Diseases Pub Date : 2026-01-01 DOI: 10.4084/MJHID.2026.015
Sophia Delicou, Katerina Xydaki, Maria Moraki, Theodoros Aforozis
{"title":"End-of-Life Care in Sickle Cell Disease and Transfusion-Dependent β-Thalassemia: Clinical, Psychosocial, and Ethical Considerations.","authors":"Sophia Delicou, Katerina Xydaki, Maria Moraki, Theodoros Aforozis","doi":"10.4084/MJHID.2026.015","DOIUrl":"10.4084/MJHID.2026.015","url":null,"abstract":"<p><p>Sickle cell disease (SCD) and transfusion-dependent β-thalassemia are no longer pediatric death sentences. With newborn screening, transfusions, and chelation therapy, patients now survive into their 4th-6th decade. Yet as they age, they face mounting complications -pain that never truly resolves, organs failing one by one, and profound isolation. Ironically, palliative care remains scarce despite the clinical complexity. This narrative review examines end-of-life care in these hemoglobinopathies, focusing on pain management, ethical tensions, and the psychosocial needs that intensify as death approaches. We reviewed literature from 2020 to 2025, international guidelines, and European frameworks. The evidence is clear: terminal SCD involves unpredictable crises and intractable pain; β-thalassemia brings slow cardiac decline and iron-laden organ failure. Both demand early palliative integration, yet both are drastically undertreated. Cultural beliefs heavily shape how families accept or reject end-of-life discussions. Disparities in opioid access, lack of disease-specific referral criteria, and absence of flexible hospice models create barriers that disproportionately harm marginalized patients. We conclude that hemoglobinopathy patients deserve the same anticipatory, culturally informed, multidisciplinary palliative care that we increasingly offer to cancer patients. Health systems must establish referral pathways specific to these diseases, permit palliative transfusions in hospice when appropriate, ensure equitable opioid access, and embed psychosocial support in hemoglobinopathy centers.</p>","PeriodicalId":18498,"journal":{"name":"Mediterranean Journal of Hematology and Infectious Diseases","volume":"18 1","pages":"e2026015"},"PeriodicalIF":1.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12867032/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146119435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CD20 Loss as a Mechanism of Resistance to Mosunetuzumab in Relapsed Follicular Lymphoma. CD20缺失作为复发性滤泡性淋巴瘤耐药机制
IF 1.5 4区 医学
Mediterranean Journal of Hematology and Infectious Diseases Pub Date : 2026-01-01 DOI: 10.4084/MJHID.2026.014
Martina Canichella, Stefano Fratoni, Carla Mazzone, Alice Di Rocco, Elisabetta Abruzzese
{"title":"CD20 Loss as a Mechanism of Resistance to Mosunetuzumab in Relapsed Follicular Lymphoma.","authors":"Martina Canichella, Stefano Fratoni, Carla Mazzone, Alice Di Rocco, Elisabetta Abruzzese","doi":"10.4084/MJHID.2026.014","DOIUrl":"10.4084/MJHID.2026.014","url":null,"abstract":"","PeriodicalId":18498,"journal":{"name":"Mediterranean Journal of Hematology and Infectious Diseases","volume":"18 1","pages":"e2026014"},"PeriodicalIF":1.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12867029/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146118511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书